Home » New Drugs

Mylan resolves Caduet tablets patent dispute with Pfizer
0
Mylan has signed a settlement agreement with Pfizer to resolve litigation related to Caduet tablets. What is Caduet? According to Drugs.com, Caduet contains a combination of amlodipine and atorvastatin. Atorvastatin is a HMG CoA reductase inhibitor,...

Continue Reading »

FDA approves Merck HPV vaccine

FDA approves Merck HPV vaccine

Posted by on December 26, 2010
1
FDA approves Merck HPV vaccine for anal cancer, AIN prevention The US Food and Drug Administration (FDA) has approved new indication for Merck’s Gardasil [Human Papillomavirus Quadrivalent (Types 6, 11, 16, and 18) Vaccine, Recombinant] for the...

Continue Reading »

FDA approves Amturnide a Novartis high BP drug

FDA approves Amturnide a Novartis high BP drug

Posted by on December 26, 2010
0
FDA approves Novartis high BP drug Amturnide The US Food and Drug Administration (FDA) has approved Novartis’ high blood pressure treatment, Amturnide (aliskiren, amlodipine and hydrochlorothiazide) tablets on the basis of the data from a double-blind,...

Continue Reading »

Pfizer files supplemental applications for Prevnar 13
1
Pfizer files supplemental applications to FDA and EMA for Prevnar 13 Pfizer has filed supplemental applications to the US Food and Drug Administration (FDA) and the European Medicines Agency (EMA) to expand the use of Prevnar 13 (Pneumococcal 13-valent...

Continue Reading »

Malaria Vaccine it’s not a dream

Malaria Vaccine it’s not a dream

Posted by on October 12, 2009
0
Malaria Vaccine it’s not a dream anymore. Vivante GMP Solutions has completed process optimisation activities related to the upcoming production of a GMP clinical plot of an Oxford University adenovirus-based malaria vaccine. The Jenner Institute...

Continue Reading »

The Innovative Medicines Initiative news

The Innovative Medicines Initiative news

Posted by on September 17, 2009
0
On Sept. 14, 2009, the Innovative Medicines Initiative (IMI), a public–private partnership between the European Commission and the European pharmaceutical industry, represented by the European Federation of Pharmaceutical Industries and Associations...

Continue Reading »